Corteva, Inc. research snapshot
CTVA AI stock analysis currently reads Corteva, Inc. as a high-quality agriculture technology company with valuable seed genetics, crop protection products, healthy free cash flow, and an important pending split into separate seed and crop protection companies. The analysis is not a certain price prediction. At the July 8, 2026 cutoff, the latest verified price used here was $86.75, market capitalization was about $58.02 billion, and the central question was whether normalized earnings growth and separation execution can support a premium valuation despite farm income, commodity price, litigation, and regulatory risk. This is informational research and not investment advice.
Current price
$86.75
Market cap
$58.02 billion
AI score
72 / 100
Rating
Quality agriculture franchise, separation-driven uncertainty
Trend status
Uptrend above major moving averages
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Corteva sells seed genetics, traits, crop protection chemicals, biologicals, and digital agronomy tools into recurring planting and crop care decisions. | High |
| Moat | The moat comes from Pioneer brand equity, germplasm, trait libraries, regulatory approvals, farmer relationships, distribution reach, scale, and R&D depth. | Medium-high |
| Management | Management has improved margins, returned capital, and is executing a complex split. The separation plan raises execution and governance risk until final structures are clear. | Medium |
| Financial trend | FY2025 net sales rose 3% to $17.40 billion, operating EBITDA rose to $3.85 billion, and Q1 2026 net sales increased 11% to $4.91 billion. | High |
| Valuation | The stock traded near 51x GAAP TTM EPS, 28.7x TTM free cash flow, 3.24x sales, and about 24x the midpoint of 2026 operating EPS guidance. | Medium |
| Technical trend | CTVA traded above its 50-day and 200-day moving averages, with daily RSI and MACD readings in buy territory but not enough to remove event risk. | Medium-high |
| Risk level | Key risks are crop commodity pressure, farmer margins, pesticide regulation, litigation, Latin America price pressure, weather, FX, and separation costs. | Medium-high |
| AI confidence | High confidence for historical financials, market cap math, share count, and technical levels. Lower confidence for post-separation valuation. | High data confidence |
| Investment certainty | Medium certainty. Corteva is a strong franchise, but the current price depends on normalized earnings growth and clean separation execution. | Medium |
CTVA AI stock forecast
The CTVA AI stock forecast uses scenario ranges around the $86.75 cutoff price. It does not claim that AI can predict a specific future price. The bullish case requires clean separation execution, resilient seed pricing, recovery in crop protection margins, and a valuation based on normalized operating earnings. The base case assumes steady mid-single-digit earnings growth and a lower premium after the split. The bearish case assumes farm income pressure, regulatory or legal costs, or a messy separation.
$135 to $161
More likely if normalized EPS compounds near low double digits, the split clarifies value, seed technology keeps pricing power, crop protection margins recover, and investors assign a premium high-20s to low-30s earnings multiple.
$95 to $110
More likely if operating EPS grows near mid-single digits, the split stays on schedule, and CTVA is valued near the low-to-mid 20s multiple range on normalized earnings.
$54 to $70
More likely if farm economics weaken, Latin America price pressure persists, legal or regulatory costs rise, and the market values the business closer to mid-teens normalized earnings.
CTVA AI technical analysis
CTVA AI technical analysis starts from the $86.75 price used for this July 8 static page. Public technical sources showed the stock above its 50-day and 200-day moving averages, with RSI in buy territory and MACD positive. Because this page does not fetch request-time market data, traders should confirm levels on a live chart before acting.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $86.75 | Latest verified market price used for this page as of the July 8, 2026 data cutoff. |
| Near support | $84 to $85 | Area around the 50-day moving average and recent pivot zone. Holding it keeps the short-term trend constructive. |
| Secondary support | $79 to $80 | Investing.com showed the 200-day moving average near $79.45, making this an important long-trend reference. |
| Deeper support | $73 to $74 | StockAnalysis showed the 200-day moving average near $73.37, so a break into this zone would signal wider technical deterioration. |
| Near resistance | $86.50 to $88 | The stock was trading near recent highs, so breakout attempts need volume confirmation and post-earnings follow-through. |
| 50-day moving average | $80.04 to $84.32 | StockAnalysis and Investing.com showed different 50-day references, but both placed CTVA above the average. |
| 200-day moving average | $73.37 to $79.45 | Both technical sources showed CTVA above the 200-day moving average, supporting the longer trend. |
| Momentum | RSI 62.10 to 74.01, MACD 0.750 | Momentum is constructive, but RSI near the upper range makes chasing less attractive without a defined stop. |
| Volume | 20-day average volume about 4.58 million shares | Breakouts above the high zone should be confirmed by volume near or above recent averages. |
| Invalidation | Close below $84, then $79 | A close below the 50-day area weakens the near-term setup. A break below the 200-day area would challenge the long trend. |
CTVA AI trading strategy
The CTVA AI trading strategy is a rules-based framework, not personalized advice. It combines filing-backed fundamentals, separation milestones, trend confirmation, position sizing, and clear invalidation levels.
Look for CTVA to hold above the 50-day area and break above the $86.50 to $88 resistance zone with volume confirmation before treating momentum as confirmed.
A failed breakout or daily close below the $84 to $85 area should reduce confidence in the setup.
If CTVA pulls back toward $79 to $84 while Q2 results and separation milestones remain intact, compare the entry with normalized EPS, FCF yield, and farm input demand.
Do not average down only because the business has strong technology. Define maximum loss and re-check crop cycle and legal risk first.
Track July 30, 2026 earnings, operating EPS guidance, seed pricing, crop protection volume, Latin America price trends, separation Form 10 updates, and capital structure details.
Lower the rating if normalized EPS guidance weakens while the stock still trades at a premium multiple.
Investment research summary
Corteva helps farmers raise and protect crop yields through seed genetics, traits, crop protection chemistry, biologicals, and agronomy data.
The moat is built on Pioneer seed brand trust, proprietary germplasm, traits, product registrations, farmer relationships, distribution, and global R&D scale.
The thesis can fail if farm economics deteriorate, pesticide rules tighten, litigation costs rise, Latin America pricing stays weak, or the split destroys focus instead of unlocking value.
Management has improved productivity, returned more than $1.5 billion to shareholders in 2025, and is pursuing a split into seed and crop protection businesses. Execution risk remains high until separation is complete.
Food demand, yield pressure, biologicals, gene editing, and climate stress support long-term ag technology demand, but grower spending is cyclical and tied to crop prices.
At $86.75, CTVA priced in a meaningful amount of normalized earnings recovery. Margin of safety depends on operating EPS growth, post-split clarity, and avoiding legal or regulatory surprises.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CTVA price | $86.75 on July 8, 2026 | Market price snapshot and StockAnalysis quote context | July 8, 2026 |
| Market capitalization | $58.02 billion, verified as $86.75 x 668,820,000 shares | financial_rigor.py market cap verification and Corteva Q1 2026 Form 10-Q | July 8, 2026 |
| Shares outstanding | 668.82 million shares at April 29, 2026 | Corteva Q1 2026 Form 10-Q and StockAnalysis statistics | July 8, 2026 |
| FY2025 net sales | $17.40 billion, cross-validated at $17.401 billion | Corteva FY2025 release, StockAnalysis, and Macrotrends | July 8, 2026 |
| FY2025 net income attributable to Corteva | $1.094 billion, cross-validated across three sources | Corteva FY2025 release, StockAnalysis, and MarketBeat | July 8, 2026 |
| Q1 2026 net sales | $4.905 billion, up 11% year over year | Corteva Q1 2026 earnings release | July 8, 2026 |
| Q1 2026 operating EPS guidance | Full-year 2026 operating EPS expected at $3.45 to $3.70 | Corteva Q1 2026 earnings release | July 8, 2026 |
| Cash and debt | $1.97 billion cash and $3.36 billion total debt at March 31, 2026 | Corteva Q1 2026 Form 10-Q, StockAnalysis, and Simply Wall St | July 8, 2026 |
| Segment mix | FY2025 Seed net sales $9.898B; Crop Protection net sales $7.503B | Corteva FY2025 release and PR Newswire mirror | July 8, 2026 |
| Planned separation | Corteva remains on track to complete the planned separation in the second half of 2026 | Corteva Q1 2026 separation update | July 8, 2026 |
| Moving averages and momentum | 50-day MA $80.04 to $84.32, 200-day MA $73.37 to $79.45, RSI 62.10 to 74.01, MACD 0.750 | StockAnalysis and Investing.com technical snapshots | July 8, 2026 |
| Valuation math | 51.03x GAAP TTM PE, 28.73x P/FCF, 3.48% FCF yield, 3.24x sales | financial_rigor.py valuation verification | July 8, 2026 |
This CTVA AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of July 8, 2026 and can be wrong.
